Back to search

Article

Niclosamide potentiates TMEM16A and induces vasoconstriction

2023-08-02

Abstract excerpt

<h4>ABSTRACT</h4> The TMEM16A calcium-activated chloride channel is a promising therapeutic target for various diseases. Niclosamide, an anthelmintic medication, has been considered as a TMEM16A inhibitor for treating asthma and chronic obstructive pulmonary disease, but was recently found to possess broad-spectrum off-target effects. Here we show that, under physiological conditions, niclosamide acutely potentia...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c7eb1477-279c-5095-8598-ac681d19ac14
DOI
10.1101/2023.07.31.551400
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Niclosamide potentiates TMEM16A and induces vasoconstrictionDOI 10.1101/2023.07.31.551400
Select a neighboring publication to make it the new centre.